share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

西維斯健康 | 4:持股變動聲明-高管 Mandadi Tilak
美股SEC公告 ·  09/04 05:51

Moomoo AI 已提取核心訊息

On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
2024年8月31日,CVS Health Corp的執行副總裁兼首席技術官曼達迪·提拉克以每股57.24美元的價格完成了共計13,097股普通股的出售。該交易根據交易代碼「F」進行,表示通過交付或扣押證券支付行權價格或稅款責任,使總市值達到749,672.28美元。在此次出售之後,提拉克在CVS Health Corp的直接持股爲40,414股。
2024年8月31日,CVS Health Corp的執行副總裁兼首席技術官曼達迪·提拉克以每股57.24美元的價格完成了共計13,097股普通股的出售。該交易根據交易代碼「F」進行,表示通過交付或扣押證券支付行權價格或稅款責任,使總市值達到749,672.28美元。在此次出售之後,提拉克在CVS Health Corp的直接持股爲40,414股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息